Adult bone marrow derived mesenchymal stem cells offer the potential to open a new frontier in medicine. Regenerative medicine aims to replace effete cells in a broad range of conditions associated with damaged cartilage, bone, muscle, tendon and ligament. However the normal process of immune rejection of mismatched allogeneic tissue would appear to prevent the…
Journal of Inflammation Template
Write in a clean editor, then format for Journal of Inflammation in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of Inflammation format
Journal of Inflammation is a peer-reviewed journal published by BMC (BioMed Central), covering Immune Response and Inflammation, Asthma and respiratory diseases, Immune cells in cancer. Over its lifetime it has published 872 papers, which have received 29,400 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Journal of Inflammation. 2023;12(3):45–58.
Formats any DOI in Journal of Inflammation style. No sign-up. |
| Publishes research in | Immune Response and Inflammation Asthma and respiratory diseases Immune cells in cancer Neutrophil, Myeloperoxidase and Oxidative Mechanisms Adipokines, Inflammation, and Metabolic Diseases |
| ISSN | 1476-9255 |
| Citation impact (2-yr) | 4.72 |
| h-index | 81 |
| i10-index | 586 |
| Article processing charge | $2,318 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Imperial College London |
| Journal website | journal-inflammation.biomedcentral.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of Inflammation per year
Citation impact of Journal of Inflammation by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of Inflammation
Interleukin (IL)-33 is a new member of the IL-1 superfamily of cytokines that is expressed by mainly stromal cells, such as epithelial and endothelial cells, and its expression is upregulated following pro-inflammatory stimulation. IL-33 can function both as a traditional cytokine and as a nuclear factor regulating gene transcription. It is thought to function as…
BACKGROUND: The Janus kinase (JAK) family of tyrosine kinases includes JAK1, JAK2, JAK3 and TYK2, and is required for signaling through Type I and Type II cytokine receptors. CP-690,550 is a potent and selective JAK inhibitor currently in clinical trials for rheumatoid arthritis (RA) and other autoimmune disease indications. In RA trials, dose-dependent decreases in…
BACKGROUND: Emerging data indicate that gut-derived endotoxin may contribute to low-grade systemic inflammation in insulin resistant states. This study aimed to examine the importance of serum endotoxin and inflammatory markers in non-alcoholic fatty liver disease (NAFLD) patients, with and without type 2 diabetes mellitus (T2DM), and to explore the effect of treatment with a lipase…
Acute lung injury (ALI) affects over 10% of patients hospitalised in critical care, with acute respiratory distress syndrome (ARDS) being the most severe form of ALI and having a mortality rate in the region of 40%. There has been slow but incremental progress in identification of biomarkers that contribute to the pathophysiology of ARDS, have…